InvestSMART

Biotron Limited (ASX: BIT) - Announcements

- Current share price for BIT : $0.002

ASX company news and announcements for Biotron Limited (BIT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Biotron Limited (BIT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Biotron Limited (BIT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Biotron Limited (BIT)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$6 Appendix 4G and Corporate Governance Statement 27 Aug 2021 12:49PM $0.053 $0.002 fallen by 96.23%
$6 Quarterly Activities Report 30 Jul 2021 9:45AM $0.056 $0.002 fallen by 96.43%
$6 Quarterly Appendix 4C Cash Flow Report 30 Jul 2021 9:43AM $0.056 $0.002 fallen by 96.43%
$6 Letter to Shareholders 8 Jul 2021 9:57AM $0.061 $0.002 fallen by 96.72%
$6 Notification of cessation of securities - BIT 1 Jul 2021 3:31PM $0.051 $0.002 fallen by 96.08%
$6 $1.4M R&D Tax Rebate 29 Apr 2021 9:02AM $0.064 $0.002 fallen by 96.88%
$6 Quarterly Activities Report 28 Apr 2021 4:23PM $0.064 $0.002 fallen by 96.88%
$6 Appendix 4C - quarterly 28 Apr 2021 4:23PM $0.064 $0.002 fallen by 96.88%
$6 Lead Series for SARS-COV-2 Program 11 Mar 2021 11:26AM $0.065 $0.002 fallen by 96.92%
$6 Half Yearly Report and Accounts 23 Feb 2021 4:17PM $0.071 $0.002 fallen by 97.18%
$6 Quarterly Activities Report 29 Jan 2021 9:09AM $0.079 $0.002 fallen by 97.47%
$6 Quarterly Cashflow Report 29 Jan 2021 8:30AM $0.079 $0.002 fallen by 97.47%
$6 Results of Meeting 19 Nov 2020 12:03PM $0.087 $0.002 fallen by 97.70%
$6 Presentation to Annual General Meeting 19 Nov 2020 11:15AM $0.086 $0.002 fallen by 97.67%
$6 Quarterly Activities Report 29 Oct 2020 12:20PM $0.084 $0.002 fallen by 97.62%
$6 Quarterly Cashflow Report 29 Oct 2020 12:19PM $0.084 $0.002 fallen by 97.62%
$6 BIT225 HIV-1 Immunomodulatory Paper Published 15 Oct 2020 9:59AM $0.096 $0.002 fallen by 97.92%
$6 Presentation to Investors 14 Oct 2020 3:14PM $0.100 $0.002 fallen by 98%
$6 Annual Report and Notice of Annual General Meeting 9 Oct 2020 10:23AM $0.092 $0.002 fallen by 97.83%
$6 Biotron Compounds Show Activity Against SARS-CoV-2 Virus 7 Sep 2020 9:23AM $0.095 $0.002 fallen by 97.89%
$6 Trading Halt 3 Sep 2020 2:43PM $0.095 $0.002 fallen by 97.89%
$6 Pause in Trading 3 Sep 2020 10:52AM $0.095 $0.002 fallen by 97.89%
$6 Full Year Statutory Accounts 27 Aug 2020 4:46PM $0.099 $0.002 fallen by 97.98%
$6 Appendix 4G and Corporate Governance Statement 27 Aug 2020 4:45PM $0.099 $0.002 fallen by 97.98%
$6 Quarterly Activities Report 29 Jul 2020 2:48PM $0.097 $0.002 fallen by 97.94%

226 - 250 of 597 results

Page 10 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.